U.S. FDA advisory panel votes in favor of Johnson & Johnson’s Covid-19 vaccine
U.S. FDA advisory panel votes in favor of Johnson & Johnson’s COVID-19 vaccine
(Reuters) – A panel of expert advisers to the U.S. Food and Drug Administration (FDA) on Friday voted in favor of authorizing Johnson & Johnson’s COVID-19 vaccine for emergency use, bringing it an important step closer to a U.S. rollout.
The FDA is likely to authorize the one-shot vaccine within a day or so after receiving the recommendation of the panel, making it the third available in the United States.
Reporting by Manas Mishra in Bengaluru; editing by Peter Henderson
FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Our Standards: The Thomson Reuters Trust Principles.
Reuters source:
